HAP Trading’s Aimmune Therapeutics AIMT Stock Holding History

HAP Trading’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,400	Closed	-$89K	–	1620
2019 Q4	$89K	Hold	12,400	–	–	﹤0.01%	577
2019 Q3	$6K	Buy	+12,400	New	+$253K	﹤0.01%	1116
2019 Q2	–	Sell	-10,900	Closed	-$6K	–	1405
2019 Q1	$6K	Buy	+10,900	New	+$257K	﹤0.01%	997
2018 Q2	–	Sell	-30,200	Closed	-$99K	–	1194
2018 Q1	$99K	Buy	+30,200	New	+$1.06M	0.01%	554

Other funds holding AIMT

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fiera Capital (Canada)

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return